B. Tjoa et al., PRESENTATION OF PROSTATE TUMOR-ANTIGENS BY DENDRITIC CELLS STIMULATEST-CELL PROLIFERATION AND CYTOTOXICITY, The Prostate, 28(1), 1996, pp. 65-69
Dendritic cells (DCs) are ''professional'' antigen-presenting cells ca
pable of stimulating T-cell proliferation and cytotoxicity when loaded
with and presenting specific antigens, including tumor antigens. We d
emonstrated the stimulation of an autologous cytotoxic T-cell response
elicited by DC loaded with autologous tumor cell lysate derived from
primary prostate tumor. A candidate tumor antigen is prostate-specific
membrane antigen (PSMA), which is overexpressed in prostate cancer pa
tients. We identified a HLA-A2 motif in PSMA, isolated patient DC, loa
ded peptide into DC, and stimulated autologous T cells to proliferate.
The ability to use DC for presentation of either tumor or peptide ant
igen in an HLA-restricted fashion in order to stimulate T-cell prolife
ration and cytotoxicity demonstrates the potential of this technology
for development of a prostate cancer vaccine. (C) 1996 Wiley-Liss, Inc
.